BIOTECHNOLOGY VALUE FUND L P 13D/13G Filings for Sutro Biopharma, Inc. (STRO)

BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for Sutro Biopharma, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2024-11-14
4:30 pm
Sale		 2024-09-30 13G Sutro Biopharma, Inc.
STRO		 BIOTECHNOLOGY VALUE FUND L P 0
0.000%		 -3,347,946decrease
(Position Closed)		 Filing
2023-02-14
11:45 am
Purchase		 2022-12-31 13G Sutro Biopharma, Inc.
STRO		 BIOTECHNOLOGY VALUE FUND L P 3,347,946
5.800%		 187,530increase
(+5.93%)		 Filing
2022-01-18
5:18 pm
Purchase		 2022-01-07 13G Sutro Biopharma, Inc.
STRO		 BIOTECHNOLOGY VALUE FUND L P 3,160,416
6.800%		 1,306,254increase
(+70.45%)		 Filing
2021-02-12
4:25 pm
Sale		 2020-12-31 13G Sutro Biopharma, Inc.
STRO		 BIOTECHNOLOGY VALUE FUND L P 1,854,162
4.100%		 -514,230decrease
(-21.71%)		 Filing
2020-05-22
5:22 pm
Purchase		 2020-05-12 13G Sutro Biopharma, Inc.
STRO		 BIOTECHNOLOGY VALUE FUND L P 2,368,392
6.600%		 2,368,392increase
(New Position)		 Filing